Toi, Yukihiro, et al. “Association of Low Body Surface Area With Dose Reduction and or Discontinuation of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis: a Pilot Study: BSA and Nintedanib Reduction Discontinuation”. Sarcoidosis, Vasculitis and Diffuse Lung Diseases, vol. 36, no. 1, Mar. 2019, pp. 74-78, https://doi.org/10.36141/svdld.v36i1.7383.